These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae. Chotikanatis K; Kohlhoff SA; Hammerschlag MR Antimicrob Agents Chemother; 2014; 58(3):1800-1. PubMed ID: 24366753 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of Chlamydia trachomatis Growth During the Last Decade: A Mini-Review. Serradji N; Vu TH; Kim H; Panyam J; Verbeke P Mini Rev Med Chem; 2018; 18(16):1363-1372. PubMed ID: 29692244 [TBL] [Abstract][Full Text] [Related]
28. Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis. Wyrick PB; Davis CH; Raulston JE; Knight ST; Choong J Clin Infect Dis; 1994 Nov; 19(5):931-6. PubMed ID: 7893882 [TBL] [Abstract][Full Text] [Related]
29. Characterization of in vitro chlamydial cultures in low-oxygen atmospheres. Juul N; Jensen H; Hvid M; Christiansen G; Birkelund S J Bacteriol; 2007 Sep; 189(18):6723-6. PubMed ID: 17631631 [TBL] [Abstract][Full Text] [Related]
30. A novel protease inhibitor causes inclusion vacuole reduction and disrupts the intracellular growth of Chlamydia trachomatis. Zhou Y; Lu X; Huang D; Lu Y; Zhang H; Zhang L; Yu P; Wang F; Wang Y Biochem Biophys Res Commun; 2019 Aug; 516(1):157-162. PubMed ID: 31202460 [TBL] [Abstract][Full Text] [Related]
31. Antimicrobial Resistance Screening in Chlamydia trachomatis by Optimized McCoy Cell Culture System and Direct qPCR-Based Monitoring of Chlamydial Growth. Meštrović T; Virok DP; Ljubin-Sternak S; Raffai T; Burián K; Vraneš J Methods Mol Biol; 2019; 2042():33-43. PubMed ID: 31385269 [TBL] [Abstract][Full Text] [Related]
32. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Wolf K; Betts HJ; Chellas-Géry B; Hower S; Linton CN; Fields KA Mol Microbiol; 2006 Sep; 61(6):1543-55. PubMed ID: 16968227 [TBL] [Abstract][Full Text] [Related]
38. Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents. Masson ND; Toseland CD; Beale AS Antimicrob Agents Chemother; 1995 Sep; 39(9):1959-64. PubMed ID: 8540698 [TBL] [Abstract][Full Text] [Related]
39. Synergistic effect of ultrasound and antibiotics against Chlamydia trachomatis-infected human epithelial cells in vitro. Ikeda-Dantsuji Y; Feril LB; Tachibana K; Ogawa K; Endo H; Harada Y; Suzuki R; Maruyama K Ultrason Sonochem; 2011 Jan; 18(1):425-30. PubMed ID: 20728399 [TBL] [Abstract][Full Text] [Related]
40. How useful is the Chlamydia micro-immunofluorescence (MIF) test for the gynaecologist? Wagenvoort JH; Koumans D; van de Cruijs M Eur J Obstet Gynecol Reprod Biol; 1999 May; 84(1):13-5. PubMed ID: 10413220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]